Table 4.
The inhibitory concentrations (IC50) of ethanol extracts (PPEs) of pomegranate (Punica granatum L.) peels on normal human fibroblasts (WI38), cervical carcinoma (HeLa), colorectal adenocarcinoma, metastatic (SW620), breast epithelial adenocarcinoma, metastatic (MCF-7), pancreatic carcinoma (MIA PaCa-2) and pancreatic adenocarcinoma, derived from metastatic liver (CFPAC-1).
Sample | IC50 1 | |||||
---|---|---|---|---|---|---|
WI-38 | HeLa | SW620 | MCF-7 | MIA PaCa-2 | CFPAC-1 | |
P1 | 0.197 | 0.212 | 0.255 | 0.239 | 0.219 | 0.334 |
P2 | 0.245 | 0.167 | 0.223 | 0.198 | 0.164 | 0.274 |
P3 | 0.205 | 0.185 | 0.208 | 0.219 | 0.191 | 0.331 |
P4 | 0.151 | 0.141 | 0.163 | 0.162 | 0.136 | 0.197 |
P5 | 0.214 | 0.212 | 0.354 | 0.272 | 0.216 | 0.365 |
P6 | 0.319 | 0.145 | 0.209 | 0.173 | 0.132 | 0.234 |
P7 | 0.160 | 0.191 | 0.317 | 0.268 | 0.203 | 0.353 |
P8 | 0.396 | 0.196 | 0.304 | 0.303 | 0.177 | 0.370 |
1 IC50—Concentration (mg/mL) required for inhibition of cancer cell proliferation by 50%.